Matthew Stanton Biography and Net Worth

Matt served as vice president, head of chemistry and platform immunology at Moderna from 2014 – 2017. Matt was director and head of RNA medicinal chemistry at Merck, spending 16 years in several roles including small molecule program leadership and head of chemistry capabilities enhancement. He was involved in numerous therapeutic areas including oncology, cardiovascular, neuroscience and infectious disease that spanned a range of modalities including small molecules, siRNA and peptide conjugates. Matt graduated from Virginia Tech with a Bachelor of Science in chemistry and earned his doctorate in chemistry from the University of North Carolina at Chapel Hill, with a focus on physical organic chemistry and natural product synthesis.

What is Matthew Stanton's net worth?: The estimated net worth of Matthew Stanton is at least $551,045.04 as of June 15th, 2021. Dr. Stanton owns 199,654 shares of Generation Bio stock worth more than $551,045 as of April 19th. This net worth evaluation does not reflect any other assets that Dr. Stanton may own. Additionally, Dr. Stanton receives an annual salary of $654,830.00 as Insider at Generation Bio. Learn More about Matthew Stanton's net worth.
How old is Matthew Stanton?: Dr. Stanton is currently 50 years old. There are 7 older executives and no younger executives at Generation Bio. The oldest executive at Generation Bio is Dr. Robert Kotin Ph.D., Co-Founder, who is 68 years old. Learn More on Matthew Stanton's age.
What is Matthew Stanton's salary?: As the Insider of Generation Bio Co., Dr. Stanton earns $654,830.00 per year. The highest earning executive at Generation Bio is Dr. Cameron Geoffrey McDonough M.D., President, CEO & Director, who commands a salary of $939,090.00 per year. Learn More on Matthew Stanton's salary.
How do I contact Matthew Stanton?: The corporate mailing address for Dr. Stanton and other Generation Bio executives is 301 BINNEY STREET, CAMBRIDGE MA, 02142. Generation Bio can also be reached via phone at 617-655-7500 and via email at [email protected]. Learn More on Matthew Stanton's contact information.
Has Matthew Stanton been buying or selling shares of Generation Bio?: Matthew Stanton has not been actively trading shares of Generation Bio during the past quarter. Most recently, Matthew Stanton sold 1,500 shares of the business's stock in a transaction on Monday, August 23rd. The shares were sold at an average price of $25.04, for a transaction totalling $37,560.00. Learn More on Matthew Stanton's trading history.
Who are Generation Bio's active insiders?: Generation Bio's insider roster includes Douglas Kerr (Insider), Geoff McDonough (CEO), Jason Rhodes (Director), Evan Spiegel (CEO), and Matthew Stanton (Insider). Learn More on Generation Bio's active insiders.
Are insiders buying or selling shares of Generation Bio?: In the last twelve months, Generation Bio insiders bought shares 2 times. They purchased a total of 12,637 shares worth more than $19,159.34. In the last twelve months, insiders at the sold shares 4 times. They sold a total of 11,591 shares worth more than $49,239.96. The most recent insider tranaction occured on January, 2nd when COO Antoinette Paone sold 2,445 shares worth more than $3,960.90. Insiders at Generation Bio own 20.8% of the company. Learn More about insider trades at Generation Bio.
Information on this page was last updated on 1/2/2024.

Matthew Stanton Insider Trading History at Generation Bio

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/23/2021	Sell	1,500	$25.04	$37,560.00
8/10/2021	Sell	1,500	$22.63	$33,945.00
7/12/2021	Sell	3,000	$25.03	$75,090.00
6/15/2021	Sell	1,500	$28.08	$42,120.00	199,654
6/10/2021	Sell	6,000	$27.23	$163,380.00	204,154
5/27/2021	Sell	1,500	$34.05	$51,075.00	199,654
5/11/2021	Sell	400	$31.05	$12,420.00	206,754
4/22/2021	Sell	3,000	$32.55	$97,650.00
4/16/2021	Sell	1,500	$28.03	$42,045.00	199,654
4/12/2021	Sell	6,000	$26.24	$157,440.00	204,154
3/10/2021	Sell	10,500	$34.97	$367,185.00	208,654
1/14/2021	Sell	5,630	$32.54	$183,200.20	203,784
12/10/2020	Sell	10,540	$37.62	$396,514.80	208,694

Matthew Stanton Buying and Selling Activity at Generation Bio

Generation Bio Company Overview

Generation Bio Co. develops non-viral genetic medicines for the treatment of rare and prevalent diseases. The company develops cell-targeted lipid nanoparticle (ctLNP) platform, a modular delivery system for nucleic acids to avoid off-target clearance by the liver and spleen that enables ctLNPs to persist in systemic circulation, which allows for highly selective and potent ligand-driven targeting to specific tissues and cell types; and novel immune-quiet DNA (iqDNA) to enable long-lasting high levels of gene expression from non-integrating episomes and avoids innate immune sensors that have long prevented DNA from use in non-viral systems. It uses its platform for developing a portfolio of programs for treating cancer, autoimmune, hematologic disorders, prioritizing sickle cell, beta-thalassemia, and hemophilia A diseases, as well as for other tissues and cell types, including retina, skeletal muscle, and central nervous system. The company was formerly known as Torus Therapeutics, Inc. and changed its name to Generation Bio Co. in November 2017. Generation Bio Co. was incorporated in 2016 and is headquartered in Cambridge, Massachusetts.

Today's Range

Now: $2.76

$2.70

$2.84

50 Day Range

MA: $3.04

$1.92

$4.35

2 Week Range

Now: $2.76

$0.86

$6.98

Volume

58,715 shs

Average Volume

271,063 shs

Market Capitalization

$183.48 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.79

Biden’s $374B Giveaway Into This Sector

From DTI | Ad

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

Click here for the full story

Matthew Stanton Biography and Net Worth

What is Matthew Stanton's net worth?

How old is Matthew Stanton?

What is Matthew Stanton's salary?

How do I contact Matthew Stanton?

Has Matthew Stanton been buying or selling shares of Generation Bio?

Who are Generation Bio's active insiders?

Are insiders buying or selling shares of Generation Bio?